Rising Incidence of Hemophilia, Immunological Disorders, and the Growing Number of Surgical Procedures Worldwide is Driving Growth, at a CAGR of ~9%Dublin, Feb. 06, 2025 (GLOBE NEWSWIRE) -- The "Blood ...

Short GRFS slightly under 7.02, target n/a, stop loss @ 7.04 Check the time stamp on this data. Updated AI-Generated Signals ...

Q3 2025 Earnings Conference Call February 6, 2025 8:30 AM ETCompany ParticipantsOlga Guyette - Vice President, ...

ADMA Biologics' growth potential with Asceniv makes it a compelling Buy. Click here to find out why ADMA stock is a Strong ...

UEFA has today announced that Unilever, a global leader in consumer goods, has become an official global partner of UEFA ...

Q3 2025 Management View CEO Christopher Simon reported third-quarter revenue of $349 million, a 4% increase on a reported basis, with adjusted EPS rising 14% to $1.19. He highlighted the company's ...

Haemonetics Corporation (market cap: $3.23B) reported its third-quarter earnings for fiscal year 2024, surpassing analysts' expectations with an adjusted earnings per share (EPS) of $1.19, slightly ...